Prognostic relevance of 46 clinical, "classical" laboratory and oncological parameters in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Holden-rieder, S
von Pawel, J
Heinemann, V
Raith, H
Feldmann, K
Stenman, UH
Nagel, D
Stieber, P
机构：
[1] Univ Munich, Klinikum Grosshadern, Inst Clin Chem, D-8000 Munich, Germany
[2] Asklepios Hosp, Gauting, Germany
[3] Univ Munich, Klinikum Grosshadern, Med Clin 2, D-8000 Munich, Germany
[4] Univ Helsinki, Cent Hosp, Helsinki, Finland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：669S / 669S
页数：1
相关论文
共 50 条
  • [41] PROGNOSTIC FACTORS FOR ADVANCED NON-SMALL CELL LUNG CANCER IN JAPANESE
    Mizutani, Tomonori
    Takeda, Yuichiro
    Naka, Go
    Horio, Yuko
    Fujita, Yu
    Sugiyama, Eri
    Yagishita, Shigehiro
    Ishi, Satoshi
    Hirano, Satoru
    Kobayashi, Nobuyuki
    Kudo, Kouichiro
    ANNALS OF ONCOLOGY, 2010, 21 : 25 - 25
  • [42] Prognostic factors in locally advanced non-small cell lung cancer
    Hadidene, Y.
    Kamoun, H.
    Rejeb, H.
    Greb, D.
    Akrout, I.
    Fkih, L.
    Smadhi, H.
    Megdiche, M. L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] Comparison of Glasgow prognostic score and prognostic index in patients with advanced non-small cell lung cancer
    Jiang, Ai-Gui
    Chen, Hong-Lin
    Lu, Hui-Yu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (03) : 563 - 568
  • [44] Validation of RRM1 and PTEN as prognostic parameters of outcome in non-small cell lung cancer.
    Bepler, G
    Sharma, S
    Cantor, A
    Gautam, A
    Haura, E
    Simon, G
    Sharma, A
    Sommers, E
    Robinson, L
    Lee, H
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 654S - 654S
  • [45] Comparison of Glasgow prognostic score and prognostic index in patients with advanced non-small cell lung cancer
    Ai-Gui Jiang
    Hong-Lin Chen
    Hui-Yu Lu
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 563 - 568
  • [46] Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer
    Blaes, F
    Klotz, M
    Huwer, H
    Straub, U
    Kalweit, G
    Schimrigk, K
    Schäfers, HJ
    ANNALS OF THORACIC SURGERY, 2000, 69 (01): : 254 - 258
  • [47] Perioperative anemia as prognostic factor in patients undergoing resection for non-small cell lung cancer.
    Berardi, R
    Tamburrano, T
    Fianchini, A
    Verdecchia, L
    Onofri, A
    Santinelli, A
    Scartozzi, M
    Cellerino, R
    Cascinu, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 660S - 660S
  • [48] A prognostic score based on clinical factors and biomarkers for advanced non-small cell lung cancer
    Trape, Jaume
    Montesinos, Jesus
    Catot, Silvia
    Buxo, Josep
    Franquesa, Josefina
    Sala, Maria
    Domenech, Montserrat
    Sant, Francesc
    Badal, Josep M.
    Arnau, Anna
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (03): : 257 - 262
  • [49] Prognostic significance of β2 adrenergic receptor expression in the patients with non-small cell lung cancer.
    Yazawa, Tomohiro
    Kaira, Kyoichi
    Shimizu, Akira
    Nagashima, Toshiteru
    Ohtaki, Yoichi
    Obayashi, Kai
    Asao, Takayuki
    Oyama, Tetsunari
    Takeyoshi, Izumi
    Shimizu, Kimihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Clinical relevance of chromosome abnormalities in non-small cell lung cancer
    Feder, M
    Siegfried, JM
    Balshem, A
    Litwin, S
    Keller, SM
    Liu, ZM
    Testa, JR
    CANCER GENETICS AND CYTOGENETICS, 1998, 102 (01) : 25 - 31
12345